INT 131

CAS : 315224-26-1

Ref. 3D-QMA22426

Informations sur le produit

• Nom: INT 131
• CAS: 315224-26-1

Description

INT 131 is an estrogen receptor modulator that has been shown to have a proton-pump inhibitor effect. It has the potential to be used in the treatment of bowel disease, cancer, or diabetes. INT 131 inhibits the growth of colon cancer cells in vitro and in vivo by inducing cell lysis and inhibiting inflammatory cytokines. It also has an inhibitory effect on oral hypoglycemic agents and anti-inflammatory drugs. INT 131 is a drug repositioning candidate with possible applications for treating inflammatory diseases such as inflammatory bowel disease or insulin resistance.
INT 131 is a drug repositioning candidate with possible applications for treating inflammatory diseases such as inflammatory bowel disease or insulin resistance.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 514.2 g/mol
• Formule: C₂₁H₁₂Cl₄N₂O₃S
• Degré de pureté: Min. 95%